Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas

Neuro-oncology
Agustí AlentornAhmed Idbaih

Abstract

Diffuse low-grade gliomas (LGGs) form a heterogeneous subgroup of gliomas in adults. Chromosome (chr) arms 1p/19q codeletion and IDH mutation have been shown to be closely associated with oligodendroglial phenotype and better prognosis. We sought to identify relevant biomarkers in non 1p/19q codeleted LGGs. We characterized a retrospective series of 126 LGGs using genomic arrays, microsatellite analysis, IDH sequencing, MGMT promoter methylation assay, and p53 expression analysis. Our study confirms that 1p/19q codeletion, mutually exclusive with p53 overexpression, was associated with: (i) better prognosis, (ii) oligodendroglial phenotype, (iii) MGMT promoter methylation, and (iv) IDH mutation. Interestingly, 1p/19q codeleted tumors occur in older patients at diagnosis. Our study shows that non 1p/19q codeleted LGGs can be divided in 5 main genomic subgroups: (i) 11p loss, (ii) 19q loss (iii) 7 gain, (iv) 19 gain, and (v) unclassified. In non 1p/19q codeleted LGGs, we demonstrated that (i) 11p loss is associated with astrocytoma phenotype and has an independent negative prognostic value, and (ii) 19q loss diminished the favorable prognostic value of IDH mutation. Our findings were validated in an independent cohort of 98 LGGs....Continue Reading

References

Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J S SmithR B Jenkins
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K Hoang-XuanJ Y Delattre
Sep 24, 2004·Bioinformatics·Philippe HupéEmmanuel Barillot
Jun 28, 2005·Journal of Neuropathology and Experimental Neurology·Hiroko Ohgaki, Paul Kleihues
May 24, 2006·BMC Bioinformatics·Pierre NeuvialEmmanuel Barillot
Dec 29, 2006·Annals of Neurology·Sibille EverhardJoëlle Thillet
Dec 14, 2007·International Journal of Cancer. Journal International Du Cancer·Ahmed IdbaihOlivier Delattre
Feb 21, 2009·The New England Journal of Medicine·Hai YanDarell D Bigner
Apr 30, 2010·Neurology·M LabussièreM Sanson
Nov 4, 2010·Nature Reviews. Neurology·T David Bourne, David Schiff
Nov 16, 2010·The American Journal of Pathology·Young-Ho KimHiroko Ohgaki
Mar 18, 2011·Genes, Chromosomes & Cancer·Hanne-Sofie S DahlbackSverre Heim
May 12, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christian HartmannUNKNOWN German Glioma Network
Aug 6, 2011·Molecular Cancer Research : MCR·Adriana BorrielloFulvio Della Ragione
Aug 6, 2011·Science·Chetan BettegowdaKenneth W Kinzler
Sep 19, 2012·Pharmacology & Therapeutics·H F van ThuijlJ C Reijneveld
Mar 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Patrick J KillelaHai Yan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.